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Normal prostate and some malignant prostate cancer
(PrCa) cell lines undergo acinar differentiation and form
spheroids in three-dimensional (3-D) organotypic culture.
Acini formed by PC-3 and PC-3M, less pronounced also
in other PrCa cell lines, spontaneously undergo an
invasive switch, leading to the disintegration of epithelial
structures and the basal lamina, and formation of
invadopodia. This demonstrates the highly dynamic nature
of epithelial plasticity, balancing epithelial-to-mesenchy-
mal transition against metastable acinar differentiation.
This study assessed the role of lipid metabolites on
epithelial maturation. PC-3 cells completely failed to form
acinar structures in delipidated serum. Adding back
lysophosphatidic acid (LPA) and sphingosine-1-phosphate
(S1P) rescued acinar morphogenesis and repressed inva-
sion effectively. Blocking LPA receptor 1 (LPAR1)
functions by siRNA (small interference RNA) or the
speciﬁc LPAR1 inhibitor Ki16425 promoted invasion,
while silencing of other G-protein-coupled receptors
responsive to LPA or S1P mainly caused growth arrest
or had no effects. The G-proteins Ga12/13 and Gai were
identiﬁed as key mediators of LPA signalling via
stimulation of RhoA and Rho kinases ROCK1 and 2,
activating Rac1, while inhibition of adenylate cyclase and
accumulation of cAMP may be secondary. Interfering
with these pathways speciﬁcally impeded epithelial
polarization in transformed cells. In contrast, blocking
the same pathways in non-transformed, normal cells
promoted differentiation. We conclude that LPA and
LPAR1 effectively promote epithelial maturation and
block invasion of PrCa cells in 3-D culture. The analysis
of clinical transcriptome data conﬁrmed reduced expres-
sion of LPAR1 in a subset of PrCa’s. Our study
demonstrates a metastasis-suppressor function for
LPAR1 and Ga12/13 signalling, regulating cell motility
and invasion versus epithelial maturation.
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Introduction
The mechanisms promoting local invasion and metas-
tasis of castration-resistant, late stage prostate cancer
(PrCa) are incompletely understood and poorly recapi-
tulated by standard 2-dimensional (2-D) monolayer cell
culture and invasion models (for example, transwell
migration/Boyden chambers and scratch-wound assays).
2-D models fail to support the formation of multi-
cellular structures and epithelial barriers such as the
basement membrane (BM). In contrast, advanced model
systems in three-dimensional (3-D) tumor microenvir-
onment promote the formation of organotypic struc-
tures with relevant cell–cell and cell–matrix interactions
(Brekhman and Neufeld, 2009), epithelial polarization
and differentiation. In particular, models that utilize
physiologically relevant ECM such as collagens or
laminin (Matrigel) increasingly gain relevance (Reuter
et al., 2009; Inman and Bissell, 2010; Ridky et al., 2010).
3-D cultures represent an opportunity to investigate
dynamic morphogenetic processes like epithelial-to-
mesenchymal transition (Chu et al., 2009), a central
mechanism determining tumor cell motility, invasiveness
and drug resistance (Mani et al., 2008; Kalluri and
Weinberg, 2009). We have recently reported a miniatur-
ized 3-D platform to analyze the morphology of PrCa
cell lines in laminin-rich ECM (lrECM) (Harma et al.,
2010). Malignant PC-3 and PC-3M cells initially show
normal acinar differentiation, but later undergo sponta-
neous transformation into aggressive stellate structures
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www.nature.com/onc(‘invasive switch’). After the initial formation of
invadopodia, followed by the disintegration of symme-
trical spheroids and BM degradation, malignant cells
invade the lrECM as multicellular strings, concomitant
with the re-organization of cell–cell and cell–matrix
contacts, and altered integrin cell adhesion signalling.
Lysophosphatidic acid (LPA) and sphingosine-1-
phosphate (S1P) are simple, water soluble bioactive
lipids that regulate diverse cellular functions like cell-
proliferation (Gibbs et al., 2009), differentiation (Kim
et al., 2002; Bagga et al., 2004), apoptosis (Goetzl et al.,
1999b; Deng et al., 2002), migration (Shida et al., 2003;
Hao et al., 2007; Kim et al., 2008; Wang et al., 2008;
Li et al., 2009a,b) and adhesion (Sawada et al., 2002;
Smicun et al., 2007; Devine et al., 2008) in many cell
types. Physiological LPA levels between 0.1-25mM are
found in serum (Tigyi and Miledi, 1992), ascitic
effusions (Westermann et al., 1998) and inﬂammatory
ﬂuids (Fourcade et al., 1995). Large amounts of LPA
and S1P are secreted by platelets (Eichholtz et al., 1993),
adipocytes (Valet et al., 1998) and ﬁbroblasts (Fukami
and Takenawa, 1992; Olivera and Spiegel, 1993). LPA
and S1P mediate intracellular actions mainly via G-
protein-coupled receptors, encoded by the LPA-recep-
tors LPAR1-6 and S1P receptors S1PR1-5, and coupled
to stimulatory or inhibitory G-proteins, including Gai/o,
Gas,G aq and Ga12/13. Preferences for certain G-protein
utilization depend on the receptors, cell environment,
differentiation and adaptation to acute stress/signalling
conditions. LPA and S1P receptors trigger intracellular
signalling cascades such as Ca
2þ mobilization (Meyer zu
Heringdorf et al., 1998), activation of the Rho-GTPases,
accumulation of cytoplasmic cAMP and actin rearran-
gement, resulting in dramatic changes of cell morphology
and motility (van Dijk et al., 1998). LPA and S1P are
associated with the progression of malignancies including
ovarian (Hong et al., 1999; Fang et al., 2002), breast
(Goetzl et al., 1999a; Nava et al., 2002) and colorectal
cancers (Shida et al., 2004; Kawamori et al., 2006).
However, their functions and relevance in PrCa progres-
sion, invasion and motility remain controversial (Gibbs
et al.,2 0 0 9 ;Z e n get al., 2009). Here, we investigated the
roles of LPA and S1P, their cognate G-protein-coupled
receptor’s (Guo et al., 2006) and downstream signalling
pathways (Li et al., 2005) that regulate the switch between
acinar morphogenesis and invasion.
Results
Cell density and delipidated serum promote invasion in 3-D
The dynamics of the initial normal-like spheroid phase
formed by PC-3 cells and their spontaneous transforma-
tion into invading structures were affected by external
factors, including cell density. PC-3 cells were trans-
ferred into 3-D microwells at increasing cell densities.
Sparsely seeded cells (500–1000cells/well) develop large,
hollow spheroids lacking invasive processes for 412
days (Figure 1a, measured for 144h). Onset of invasion
is indicated by the loss of ‘roundness’, as measured by
automated image analysis (ACCA). At high density
(2500cells/well), invasion commences preferentially in
dense areas at earlier time points. Adding fresh medium
to invasive 3-D cultures results in temporary retraction
of invasive processes.
Next, medium was supplemented with increasing
quantities of fetal bovine serum (FBS). In the absence
of FBS, cells failed to form round spheroids, and
invaded the lrECM from day 1 (Figure 1b). FBS
concentrations 42.5% supported acinar morphogenesis
and suppressed invasive behavior, indicating that
differentiation-promoting factors were sufﬁciently sup-
plied by 2.5% FBS. In contrast, cultures supplemented
with charcoal-delipidated serum (CSS), removing the
most lipophilic components including LPA and S1P
(Lee et al., 1998a, 1998b), failed to develop spheroids
even at 20% FBS (Figure 1c). This indicates repression
of invasive properties by lipophilic factors.
The bioactive lipids LPA and S1P promote epithelial
maturation and suppress invasive transformation
To identify the postulated lipophilic regulators, we tested a
panel of steroids, growth factors and vitamins (Supplemen-
tary Figure S1). Re-constitution of androgens, estrogens,
progesterone, glucocorticoids, vitamin A (retinoic acid)
or D3 (cholecalciferol) failed to support acinar differ-
entiation. Next, we investigated lipids found at signi-
ﬁcant concentrations in serum, plasma and lymphatic
ﬂuids (prostaglandins, eicosanoids and thromboxanes).
Only addition of LPA and S1P effectively suppressed
invasion (Figure 2), maintaining differentiation, polari-
zation and complete BM. LPA was less potent than S1P,
with strong invasion-suppressive effects for 36h and
42h at 1.0 and 10mM, respectively (Figure 2a). With
S1P, effects lasted for 4100h (Figure 2b). In delipidated
medium (Figure 2c, CSS), the BM started to disintegrate
after 24h and was completely disrupted after 72-96h
(compare also Figure 6). Both LPA and S1P potently
repressed BM degradation and invasion. However, high
concentrations of S1P, but not LPA, caused morpho-
logical defects and disorganization of the spheroids.
Both LPA and S1P are thus potent regulators of acinar
maturation, while S1P also affects cell growth and
survival. LPA and S1P also potently blocked cell moti-
lity in monolayer settings, as shown by wound-healing
assays (Supplementary Figure S2A).
LPAR1 mediates invasion-inhibiting signals, while
LPAR2 and S1PR2 promote cell growth and proliferation
Next, we tested if siRNA knock down of the LPA
and S1P receptors compromises the invasion-blocking
effects of LPA and S1P (Figure 3a). The receptors
LPAR1-3 and S1PR2–4 were silenced by RNA
interference in monolayer culture for 72h, and
subsequently transferred into 3-D lrECM culture.
The silencing effect of each siRNA was validated by
RT–PCR. Knock down of LPAR1 in the presence of
LPA or blocking of LPAR1 with the selective com-
pound Ki-16425 (Figure 3b) caused rapid increase of
invasiveness (loss of ‘roundness’ after 24h, in contrast to
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OncogeneFigure 1 Factors supporting the invasive switch of acini formed by PC-3 cells in organotypic 3-D culture. (a) Increasing cell
density promotes conversion of differentiated acini into invasive structures (phase-contrast images from live cell imaging; left
panel). Disintegration of spheroids and invasive properties measured as loss of roundness by automated image analysis
software ACCA (right panel; measured from days 4–7 of culture). (b) Addition of 42.5% FBS supports differentiation and
suppresses invasive transformation of acini in 3-D. (c) FBS deprived of lipids by charcoal-stripping (CSS) fails to support
differentiation even at 20%.
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Oncogenescrambled siRNA), but did not affect cell growth.
In contrast, siLPAR2 resulted in proliferation-block.
Similarly, in 2-D conditions, silencing of LPAR1 and 2
caused minor effects on cell proliferation (Supplemen-
tary Figure S2B). LPAR3 silencing did not result in a
clear phenotype (not shown). Thus, LPAR1 appears as
the key factor in LPA-mediated block of invasion, and
both LPA and S1P can act via this receptor. Silencing of
S1P receptors 2, 3 and 4 in 2-D and 3-D conditions
caused growth inhibition (Supplementary Figure S2B),
but did not affect invasion (Figure 3c; loss of ‘round-
ness’). The growth-promoting effect of S1PR2 was
further validated with the speciﬁc antagonist JTE-013,
causing severe growth retardation (not shown). As
S1PR1-silencing was ineffective, we used the speciﬁc
antagonist W146, which did not affect invasiveness
(not shown).
G-protein signalling cascades downstream of LPA and
S1P receptors affect PC-3 spheroid formation and
invasive switch
Gene set enrichment analysis (Figure 4a, Supplementary
Table 1) (Mootha et al., 2003; Subramanian et al., 2005)
of mRNA expression data, comparing PrCa cells in 2-D
monolayer with early time points in 3-D culture (days
4–8), showed that a number of canonical pathways, gene
sets and gene ontology categories were signiﬁcantly
enriched in all PrCa cell lines growing in 3-D (Harma
et al., 2010), a characteristic of acinar morphogenesis.
Most signiﬁcantly induced were Rho-stimulatory Ga12/13
and Gaq signalling, whereas adenylate-cyclase activating
Gas signalling was reduced. Also adenylate-cyclase
inhibitory Gai signalling was induced, but failed false
discovery rate ﬁltering. A detailed analysis of genes
within the Ga12/13 pathway (heatmap Figure 4b)
indicated that the Rho-kinases ROCK1þ2, G-protein
Ga13 (GNA13), NF-kB p49/p100 (NF-kB2) and reg-
ulatory members of the NF-kB transcription factor
complex (NF-kBIA and NF-kBIE) were signiﬁcantly
increased in 3-D compared with 2-D culture, peaking at
days 4–8 when spheroids mature. As illustrated by
Supplementary Figure S3, differential expression also
occurred for many key components downstream of the
Ga12/13 pathway. In invading cells (d13þ15), expression
of most Ga12/13 related transcripts is subsequently
reduced. Silencing of GNA12 (Figure 4c) caused cell
elongation in 2-D and severe growth defects in 3-D,
Figure 2 Supplementing bioactive lipids LPA and S1P to CSS supports acinar differentiation and represses invasive transformation.
(a) Concentrations of 1 and 10mM LPA effectively repress invasive properties in lrECM for 36 and 42h, respectively, maintaining the
round phenotype. (b) S1P concentrations of 1 and 10mM in CSS repress invasiveness for close to 100h. (c) Immunoﬂuorescent images
of PC-3 spheroids stained for ﬁlamentous actin (F-actin) and laminin a-1 demonstrate disintegration of the actin cytoskeleton and ﬁrst
indication of the beginning disintegration of the BM after 24h exposure to 10% lipid-deprived CSS versus complete medium. In CSS
supplemented with 10mM LPA or 1mM S1P, both actin cytoskeleton and BM remain intact.
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formation. Similar results were observed with siGNA13
(not shown), which was slightly less effective in 3-D.
Furthermore, a detailed analysis of gene expression
associated with LPAR1 functions (Figure 4d) indicates a
peak of expression at days 4þ8, followed by a decline in
invasive cells (days 13þ15) and failure of induction in
CSS-treated spheroids.
Blocking the Ga12/13 RhoA/ROCK pathway induces
invasive properties in 3-D
We executed a small-scale compound screen, based on
inhibitors and activators targeting G-proteins and
downstream signalling (Figure 5a, upper panel; Supple-
mentary Table 2). Modulators of RhoA and
Rho-kinases ROCK1/2 altered invasive properties in
both 3-D and 2-D conditions (Supplementary Figure
S4). The RhoA inhibitor CCG-1423 blocked invasion,
but resulted in growth retardation, indicating a role for
RhoA in proliferation. In cells treated with ROCK
inhibitors Y-27632 and HA-1100, invadopodia formed
within 24h, similar to CSS treatment, silencing or
biochemical blocking of LPAR1. Disrupting actin-
cytoskeleton polymerization with cytochalasin-D caused
substantial growth retardation, but the remaining
structures showed pro-invasive structures. ROCK in-
hibitors effectively promoted motility in 2-D wound-
healing/scratch-wound assays (Supplementary Figure
S4A). These results indicate that LPA, LPAR1, Ga12/13,
Rho proteins and downstream effectors are fundamental
for the maturation of spheroids. Blocking these path-
ways promotes cell elongation, invadopodia formation
and invasive/migratory properties.
Figure 3 Silencing of LPA receptor 1 abolishes the invasion-inhibitory functions of LPA. (a) siRNA silencing of LPA receptors:
siLPAR1 abolishes repression of invasive properties by LPA, whereas siLPAR3 has no effect (graph). LPAR2 silencing is growth-
inhibitory (right panel). (b) Inhibition of LPAR 1 and 3 with the speciﬁc inhibitor Ki16425 effectively blocks acinar differentiation in
complete medium supplemented with 10% FBS (control), resulting in phenotypic outcome identical to CSS. (c) Silencing of S1P
receptors, S1PR3 and 4, does not affect invasive properties, and siS1PR2 results in growth retardation.
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OncogeneActivating the Gas/adenylate cyclase/cAMP pathway
promotes invasion in 3-D
LPAR1 was reported to mediate downstream actions via
Gaq and Gai/o proteins; together with Ga12/13 these
counteract the stimulatory activity of Gas signalling.
Therefore, we tested modulators of Gas downstream
signalling pathways: activity of adenylate cyclase (AC)
and phospholipase C, increased intracellular cAMP levels,
protein kinase A (PKA) and the ERK1/2 kinases (not
shown). The Gai/o inhibitors, pertussis toxin and NF023,
or Gai/o effectors melittin and mastoparan, had only
minor effects, possibly due to sequestration of peptides in
matrigel. Treatment of spheroids with forskolin, a drug
that activates AC and increases intracellular cAMP levels,
resulted in a profound loss of acinar morphology and
invasion (Figure 5a, lower panel), and an approximately
10-fold increase of intracellular cAMP levels (not shown).
Accordingly, suppressors of cAMP accumulation (BPIPP
and SQ22536) and PKA (KT-5720) effectively blocked
invasion and promoted epithelial maturation. However,
we detected only minor changes of intracellular cAMP
levels in response to CSS, or inr e s p o n s et oL P Aa n dS 1 P ,
suggesting that this mechanism may only have a secondary
role in downstream LPAR1 signalling. Possibly for this
reason, modulators of cAMP/AC had only little effects on
cell motility (Supplementary Figure S4B) or proliferation
(Supplementary Figure S4C) in 2-D wound-healing assays,
in contrast to RhoA/ROCK inhibitors.
Morphologic effects of compounds were analyzed by
automated and computational image analysis (Figure 5b
and Supplementary Figure S4. In Figure 5b, % round-
ness is used as representative measure for spheroid
maturation, typically resulting in round structures, and
usually strongly anti-correlated with measures for
invasive structures. The box and whisker plots indicate
deviation from the mean (control) as the result of lipid
depletion (CSS), and inhibition of G-proteins or down-
stream effectors. Treatment with modulators of Gao/i
did not cause measureable changes. ROCK inhibitors
(HA-1100 and Y-26732) show strong invasion-promot-
ing effects (¼reduced roundness). In contrast, RhoA-
inhibitor CCG-1423 blocks mainly proliferation and
results in small, round structures. Promoting AC
activity and increased cAMP accumulation favor inva-
siveness and reduce roundness (forskolin), while
AC/PKA inhibitors increase maturation & roundness
(BPIPP, KT5720 and SQ22536). The results of treat-
ments on morphometric parameters are illustrated by
segmented images (proprietary ACCA image analysis
software), corresponding to the 3-D compound treat-
ments (Supplementary Figure S5A). The heatmap (Sup-
plementary Figure S5B, left panel) illustrates numerical
changes of morphological image data for various treat-
ments that affect invasive processes (roundness and area
versus roughness, invasion-index, number, length or
median). Supplementary Figure S5B, right panel, shows
the Bonferroni-corrected P-values for these changes.
RhoA is counteracted by Rac and CDC42 proteins.
Thus, we treated 3-D spheroids of PC-3 cells with
Rac-inhibitors EHT-1864 (Shutes et al., 2007; Onesto
et al., 2008) and NSC-23766 (Akbar et al., 2006; Devine
et al., 2008), which blocked invasion effectively. This
indicates a role of Rac proteins in formation of invasive
structures, counteracted by RhoA in non-invasive and
differentiating spheroids. We performed western blot
analysis of PC-3 cells cultured in monolayer, compared
with non-invasive early (d5), pre-invasive late acinus stage
(d8) and invasive cells (d14) in 3-D. Furthermore, we
analyzed invasive PC-3 aggregates in CSS versus acini,
rescued with LPA (Figure 5d). RhoA activity, indicated by
high levels of inactive p-RhoA Ser-188, is temporarily
decreased in late-stage, pre-invasive acini (d8) and CSS
treatment, but increased in cells rescued with LPA.
Concomitantly, Rac1 is increased in both d14 invasive
structures and CSS treatment, but reduced in LPA-rescued
spheroids. Expression of ARHGAP1 (Rho-GTPase acti-
vating enzyme), which negatively regulates RhoA func-
tions, is increased in d8 pre-invasive and d14 invasive
structures, high in CSS-treated, but again repressed in
LPA-rescued cultures. In contrast, ARHGEF11 (Rho
guanine nucleotide exchange factor 11), which interacts
with Ga12/13 proteins and stimulates RhoA functions, is
low in monolayer and CSS treatment; but induced in early
(d5) and late (d8) acini, as well as in LPA-rescued
spheroids. Serum-response factor (SRF) expression corre-
sponds most consistently with motility and invasiveness of
PC-3 spheroids, and is highest in monolayer, invasive (d14)
spheroids and CSS-treated cultures. The lack of changes of
p-CREB1 may indicate the secondary nature of altered
cAMP levels in response to LPA, as described above.
Tumor-speciﬁc effects of cAMP activation and ROCK
inhibition in PrCa cell lines
To investigate whether the conspicuous morphological
effects in response to lipid deprivation, AC/cAMP activity
and ROCK inhibition are exclusive for PC-3 cells, we
tested a panel of additional cell lines (Figure 6 and
Supplementary Figure S6), including malignant (LNCaP
and DU145) and non-transformed, immortalized prostate
Figure 4 Evaluating the roles of G-protein signalling cascades and downstream pathways. (a) Gene Set Enrichment Analysis of
mRNA gene expression data from PC-3 cells at early time points (day 4–8) of 3-D organotypic culture. Factors indicate relative
enrichment of gene sets in 3-D compared with 2-D culture. Altered G-protein related signalling pathways highlighted in red. (b)
Heatmap of mRNA gene expression data, illustrating relative changes for genes within the Ga12/13 pathway in PC-3 cells at various
time points in 3-D culture, relative to monolayer. Multiple genes like ROCK1 are induced in well-differentiated spheroids (d4 and d8),
but reduced after the invasive switch (d13 and d15). Inducible expression is abolished in 3-D culture supplemented with 10% CSS (24
and 72h). (c) Silencing of Ga12 protein in 2-D monolayer conditions induces spindle-like morphology of PC-3 cells (upper panels). In
contrast, silencing of Ga12 in 3-D condition causes growth inhibition. (d) Heatmap of LPA receptor-associated genes at various time
points of 3-D culture and FBS versus CSS medium.
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Oncogeneepithelial cell lines (EP156T and RWPE-1). CSS, the
ROCK inhibitor Y-27632 and forskolin increased the
otherwise limited invasive properties of malignant
LNCaP cells. In contrast, treatment of non-transformed
EP156T cells promoted the maturation of highly
symmetrical spheroids, a hollow lumen, polarized
epithelial layers, and an even more complete BM
(Figure 6), Also, pre-malignant RWPE-1 and malignant
DU145 spheroids responded to CSS, Y-27632 and
forskolin, with the formation of invadopodia and
degradation of the BM (Supplementary Figure S6).
Our ﬁndings indicate that RhoA/ROCK and cAMP/
AC/PKA pathways are differentially regulated in
transformed versus non-transformed cell lines, resulting
in opposing morphologic responses.
LPAR1 is downregulated in metastatic PrCa
We next analyzed the expression of LPA and S1P
receptors in clinical mRNA expression sets (Figure 7).
In both the expO and the MSKCC transcriptome
datasets, expression of LPAR1 is reduced in PrCa
versus normal tissues, and anti-correlates with clinical
parameters associated with cancer progression and poor
Figure 5 Morphologic effects of compounds that modulate G-protein activity and key downstream signal transduction pathways.
(a) Upper panel: Compounds blocking RhoA/ROCK pathway induce invasiveness similar to LPA and S1P depletion, LPAR1 knock-
down or biochemical inhibition (upper panel; ROCK inhibitors Y-27632 and HA-1100). Direct inhibition of RhoA (CCG-1423) and
actin-cytoskeleton formation (cytochalasin D) cause proliferation-defects. Lower panel: Compounds that increase (forskolin) or reduce
intracellular cAMP levels (KT5720 and BPIPP) by modulating AC functions affect invasive conversion. (b) Analysis of morphologic
effects on spheroids, measured by the ACCA image analysis software. Altered morphology is indicated as % roundness, a measure for
epithelial maturation inversely correlating with invasive properties. The total number of spheroids measured is indicated below the box
& whisker plots. Median, 10–90% distribution (box), and 95% conﬁdence intervals (whiskers) are indicated. (c) Inhibition of Rac
family of GTPases with broad spectrum Rac-inhibitor EHT-1864 and Rac1-speciﬁc inhibitor NSC23766 block invasion at nanomolar
and micromolar concentrations, respectively. (d) Western blot analyses of key regulatory genes differentially expressed in spontaneous
and CSS-induced invasion.
Figure 6 Cell line-speciﬁc effects of ROCK inhibitors and increased cAMP levels on acinar morphogenesis versus formation of
invasive structures. Spheroids formed by PC-3, LNCaP and EP156T cells in Matrigel were stained with Alexa488-phalloidin for
ﬁlamentous F-actin, and an antibody against human laminin-a1 to highlight the BM. Inhibition of ROCK kinases (Y-27632) and
enhanced AC/increased cAMP levels (forskolin) induce invasive features and disintegration of the BM in transformed PC-3 and
LNCaP spheroids, but promote maturation of non-transformed EP156T cells.
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Oncogeneoutcome (Histological grade 43; Gleason grade 48;
positive lymph node invasion). LPAR1 shows further
decreased expression in metastatic samples compared
with primary PrCa’s. In the MSKCC data, expression of
LPAR1 is signiﬁcantly reduced in 42% of primary and
metastatic cancers (Supplementary Figure S7A; 98 of
218 tumors). The expression of other LPA and S1P
receptors like S1PR3 was also altered in PrCa’s, but not
as consistent as LPAR1. The heatmap (Supplementary
Figure S7B) illustrates anti-correlation of LPAR1 with
most other LPA/S1P receptors, except S1PR3. The high
frequency of reduced LPAR1 expression and occasional
deletion in PrCa’s is also demonstrated in Supplemen-
tary Figure S7C. Preliminary immune histochemical
staining of formalin-ﬁxed, parafﬁn-embedded PrCa
tissues with an LPAR1 antibody showed a tendency
towards reduced protein expression in Gleason Grade
4-5 and metastatic lesions (Supplementary Figure S8).
This is currently further explored using larger panels of
sections on tissue microarrays.
Discussion
LPA and LPAR1 act as potent negative regulators of
cell motility and invasion by promoting epithelial
maturation, while S1P receptors and LPA receptors
2-3 preferentially promote growth and survival (Daaka,
2002). LPA and LPAR1 thus stabilize the morphology
of acini, and block or delay the re-organization of the
actin cytoskeleton and invadopodia formation prior to
invasion. Our ﬁndings are in contrast to other reports on
PrCa (Hwang et al., 2006; Evelyn et al., 2007, 2010; Hao
et al., 2007; Hasegawa et al., 2008) breast or ovarian
cancer (Li et al., 2009a,b), but in line with ﬁndings on
melanoma (Yamaguchi et al., 2003) and colon cancers
(Shida et al., 2003, 2004), which similarly suggest a role
of LPA, LPAR1 and downstream RhoA/Rac pathways
in epithelial maturation. The Ga12/13 pathway with
downstream effectors RhoA/ROCK, and Gas pathways
with AC, cAMP, PKA and NF-kB are critical for the
maturation of acini or spheroids. Ga12/13 is signiﬁcantly
induced in 3-D conditions, whereas Gas is repressed
across all normal and cancer-derived cell lines, including
PC-3, regardless of different morphological phenotypes
(Harma et al., 2010) and invasive properties. Subse-
quently, the activity of G-proteins and downstream
effector pathways are reversed during the invasive
switch of PC-3 cells, coinciding with rearrangement of
the actin cytoskeleton, increased expression of SRF,
formation of invadopodia and degradation of the BM.
SRF activity correlates with altered F-actin structures,
collagen contraction and invasion in 3-D invasion
assays (Morin et al., 2011), and integrates the expression
of genes encoding structural and regulatory effectors of
actin dynamics (Olson and Nordheim, 2010). Similarly,
mechanisms downstream of Gas (AC, intracellular
cAMP levels and PKA) affect cell morphology and
invasiveness. In summary, LPA, LPAR1 and path-
ways downstream of Ga12/13, Gas and Gai/o promote
multicellular differentiation of PrCa cells and repress
Figure 7 mRNA expression of LPA receptor 1 (LPAR1) in clinical transcriptome data sets. (a) Expression of LPAR1 in the MSKCC
(Memorial Sloan Kettering Centre) data set. (b) Expression of LPAR1 in PrCas of the expO data set. Both histological grading as well
as Gleason grades are indicated.
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nounced in PC-3 cells, but also observed across other
transformed PrCa cell lines like LNCaP, DU145 and
22rV1. In contrast, inhibition of the same RhoA/ROCK
and activation of cAMP-related pathways in non-
transformed cells (EP156T) consistently enhanced
epithelial differentiation. The complex tumor-speciﬁc
nature of these cell biological effects, the activation of
counteracting mechanisms, such as RhoA versus Rac1
in 3-D models, and the precise role of SRF and LIM
kinases remain to be explored in more detail.
Most critical for understanding of these intercon-
nected pathways related to LPA and S1P signalling is
the use of appropriate model systems that properly
address these mechanisms in multicellular differentiation,
more similar to the (complex) clinical situation. Our
ﬁnding that LPA and S1P promote differentiation has to
take the tumor microenvironment, multicellular context,
tissue speciﬁcity and cell transformation into account.
None of the previous studies (in monolayer culture)
reporting migration-promoting effects of LPA/S1P were
based on organotypic, multicellular structures, and
unable to track invasion of cell aggregates into the
ECM. Additional studies rely on invasion models that
monitor chemotactic motility of single cells, for exam-
ple, Boyden chamber (Hope et al., 2009; Wang et al.,
2010), or scratch/wound-healing assays (Fishman et al.,
2001; Vogler et al., 2003; Wang et al., 2010). Our
experimental settings focus instead on the plasticity of
multicellular epithelial structures including the BM and
dynamic turnover of cell-matrix contacts. In particular
in PC-3 cells, this dynamic process resembles a
spontaneous epithelial-to-mesenchymal transition, trans-
forming metastable acini into mesenchymal-like, motile
cell aggregates. Our results suggest a role of LPA and S1P
in maturation of epithelia in general and prostate
glandular cells in particular.
LPAþS1P are established as central regulators of
many critical lipid-related pathways, like PPARg
(McIntyre et al., 2003; Zhang et al., 2004), and affected
by phospholipases 2A in PrCa (Sved et al., 2004; Pineiro
et al., 2010), thus linking LPA/S1P pathways to
eicosanoid/arachidonic acid pathways and regulation
of intracellular Ca
2þ. LPA was also demonstrated to
induce PC-3 migration, proliferation and survival via
Erk1/2 and Akt (Gibbs et al., 2009) or MAPK p38 and
ERK1/2 pathways (Hao et al., 2007)—again in 2-D
monolayer conditions. These studies further suggested
secretion of stimulatory chemokines, activation of
STAT3 (Jeong et al., 2008; Seo et al., 2010; Snider
et al., 2010a) and a key role for EGFR (Snider et al.,
2010b), NFkappaB and RhoA (Hwang et al., 2006) in
stimulating invasion. Similar associations were reported
for S1P (Sekine et al., 2010). These observations are in
opposition to our experimental ﬁndings, in which Ga12/13
and RhoA clearly have an important function in
stabilization of acinar structures instead.
Additionally, other controversial aspects arise, that
relate to the functions of LPAþS1P in clinical cancers.
The role of autotaxin (ENPP2) and acylglycerol kinase,
both of which produce LPA from lysophosphatidylcho-
line (Nouh et al., 2009; Zeng et al., 2009; Harper et al.,
2010), or sphingosine kinases SHPK1þ2, which
generate S1P from sphingosine (Pchejetski et al., 2008,
2010; Brizuela et al., 2010), were suggested as valid
anticancer targets (Liu et al., 2009a, 2009b), together with
LPAR1. However, reduced expression of LPAR1 in a
large portion of primary PrCa’s and distant metastases
supports our observation that the LPA/LPAR1 axis
actually promotes epithelial integrity and may also
inhibit invasive properties in vivo. LPAR1 is unique
among the LPA receptors in that it is also found in
perinuclear localization and even in the nucleus (Gobeil
et al., 2003; Waters et al., 2006). LPAR1 functions and
intracellular transport/translocation are dependent on
and regulated by RalA (Aziziyeh et al., 2009) and
caveolin (Gobeil et al., 2003), related to both inﬂamma-
tory and migratory mechanisms. Nuclear and perinuclear
localization of LPAR1 is also regulated by cell density,
Rho and ROCK inhibitors (Waters et al., 2006) and may
correlate with activation of the Phospholipase A2, AKT
and PI3Kinase pathways, as well as integrin signalling.
Within tumor tissues, LPAR1 may be employed to allow
rapid, dynamic responses to a changing microenviron-
ment. In those tumors that express signiﬁcant levels of
LPAR1, this pathway might contribute to the dynamics
of epithelial plasticity and sense changing interstitial
levels of sphingolipids and LPA, for example, in tumor
cell intravasation, extravasation and transendothelial
migration (Sequeira et al., 2008; van Golen et al.,
2008). Invading and circulating tumor cells may encoun-
ter changing levels of LPA, S1P and related lipid
signalling molecules in interstitial, lymphoid and vascular
ﬂuids, bone marrow and lymph nodes.
In summary, bioactive lipids like LPAþS1P have a
decisive role in epithelial plasticity and the regulation of
epithelial-to-mesenchymal transition, cell motility and
dynamic adaptation to changes in the cellular micro-
environment. On the basis of an organotypic 3-D cell
culture models, our ﬁndings suggest that LPAR1
functions in PrCa are considerably more complex than
previously thought, and deviate from generalized
motility-promoting properties. Our report puts a cau-
tionary note on the biological function of proposed anti-
cancer targets like LPA/S1P receptors, associated
enzymes involved in generation and turnover of LPA,
and some of their downstream modulators. Such targets
require stringent validation studies, utilizing a panel of
diverse, biologically informative and relevant model
systems.
Materials and methods
Cell lines and culture conditions
Cell lines were received from ATCC or originator laboratories.
All lines were propagated in RPMI-1640 (Sigma-Aldrich,
St Louis, MO, USA), supplemented with 10% FBS, 1%
penicillin/streptomycin and 1% l-glutamine. Immortalized
prostate epithelial cells, EP156T and RWPE-1, were cultured
in Keratinocyte Serum-Free Medium (Invitrogen, Carlsbad,
CA, USA), supplemented with 50mg/l bovine pituitary
extract, 5mg/l EGF and 2% FBS for 3-D conditions.
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4g of cell culture quality active charcoal (Sigma-Aldrich) was
mixed with 40mg of T70 dextran (GE Healthcare, Little
Chalfont, UK), 4ml of sterile 1 M Tris–HCl, 4ml of sterile 0.1 M
EDTA and sterile water to 400ml. The slurry was stirred for
2–4h at þ41C, centrifuged for 20min at 5000r.p.m., and the
supernatant discarded. Activated dextran-charcoal was mixed
with fresh FBS, and incubated twice for 30min in a shaking
water bath at þ551C. The charcoal was pelleted by centrifuga-
tion (20min, 10000r.p.m., þ41C), supernatant collected, sterile
ﬁ l t e r e dw i t h0 . 2 mM suction ﬁlters (Thermo Fisher Scientiﬁc,
Waltham, MA, USA), and stored at  201C.
Miniaturized 3-D cell cultures and morphological image analysis
with ACCA software
Miniaturized 3-D cultures were prepared as described previously
(Harma et al., 2010). Density of spheroids across all experiments
was controlled by seeding deﬁned numbers of cells in each
experiment (1000cells/well for PC-3 and 1250/well for all other
cell lines). For time-lapse experiments, 3-D cultures were imaged
with the automated live-cell imager IncuCyte (Essen Bioscience,
Ann Arbor, MI, USA). In endpoint assays, multicellular
structures were stained with calcein-AM (Invitrogen), and
apoptotic/dead cells highlighted by ethidium homodimer-2
(Invitrogen). 3-D confocal images were taken with a Zeiss
Axiovert-200M microscope with Yokogawa CSU22 spinning
disc confocal unit, and a Zeiss Plan-Neoﬂuar  5 objective.
Z-stacks were acquired with a step-size of 19mm. Intensity
projections were created with SlideBook, noise removed by
normalization. Phase-contrast time-lapse and intensity projection
images were analyzed with VTT’s proprietary ACCA software
(version 1.95). ACCA segments individual cell structures based
on morphological criteria, and assigns numerical values for
features like area (size), roundness (shape), roughness (contour),
and measures the number and length of invasive structures
(median, index and maximum extension of ‘appendages’).
Median cell density (cell Ratio) is quantiﬁed based on the ratio
of cells to background signal. Raw numerical data were further
statistically processed and visualized with R/Bioconductor.
Immunoﬂuorescence labelling and imaging
Miniaturized 3-D cultures were ﬁxed within microwells, using
2% paraformaldehyde, supplemented with 0.3% Triton X-100
(Sigma-Aldrich), 5mM EGTA and 1mM MgCl2 for 15–20min at
RT. Fixed cultures were washed 3x with PBS, and blocked for
1h with 20% horse serum. Cultures were incubated overnight at
41C, washed with PBS and incubated for 2h at RT with
secondary antibodies and Hoechst nuclear stain (1:5000). Anti-
Laminin alpha-1 antibody (LAM-89) was purchased from Santa
Cruz Biotechnology Inc. (Santa Cruz, CA, USA) anti-Ki67
antibody from Abcam (Cambridge, UK) and Alexa-conjugated
phalloidin from Invitrogen.
Immunoblotting
Protein samples were collected and lysed in WB-buffer
(25mM Hepes pH 7.5, 100mM NaCl, 5mM EDTA pH8.3,
0.5% Triton X-100, 20mM b-glycerophosphate, 100mM ortho-
vanadate, 0.5mM PMSF and 1mM DTT). Protein concentra-
tion was measured by Bradford assay, and proteins separated
by SDS-PAGE with precast PAGEr gels (Lonza, Basel,
Switzerland), transferred on Protran nitrocellulose transfer
membrane (GE Healthcare) and blotted with primary anti-
bodies. Phospho-CREB1 (Ser133; no. 9198l) antibody was
purchased from Cell Signaling Technology (Beverly, MA,
USA), phospho-RhoA (p-Ser188; no. 9198) from ECM-
Biosciences (Versailles, KY, USA), anti-Rac1 (ARC03) from
Cytoskeleton Inc. (Denver, CO, USA) and anti-ARHGEF11
(HPA011026), anti-ARHGAP1 (HPA004689) and anti-SRF
(HPA00819) from Sigma-Aldrich.
RNA interference reverse transfection
All siRNA were purchased from Qiagen (Hilden, Germany).
Cells were transfected with 81nM siRNA for 48–72h, using
siLentFect (Bio-Rad Laboratories, Inc., Hercules, CA, USA) in
Opti-MEM medium (Invitrogen). After transfection, cells were
embedded in Matrigel. Silencing efﬁcacy of siRNAs was
validated by quantitative RT–PCR (TaqMan), as described
previously (Harma et al., 2010).
Drug treatments
All compounds were purchased from Tocris Bioscience (Bristol,
UK) or Sigma-Aldrich, except for Ki16425 and JTE-013
(Cayman Chemical Company, Ann Arbor, MI, USA), W146
(Avanti Polar Lipids Inc., Alabaster, AL, USA) and CCG-1423
(Merck Chemicals Ltd., Darmstadt, Germany), and dissolved
in appropriate vehicle (DMSO, Ethanol, or PBS/water). Drug
treatments were performed in triplicates, with 2–4 different
concentrations. Lipid-depleted CSS medium was used as a
positive control to promote invasion. Multicellular structures
were stained and imaged by spinning disk confocal microscopy,
and analyzed by ACCA, as described above.
CellPlayer cell migration assays
Conﬂuent cultures on 96-well ImageLock plates (Essen Bio-
science) were scratched with WoundMaker (Essen Bioscience)
and treated with compounds for a period of 48h. Wound
closure was monitored and quantiﬁed with IncuCyte live-cell
imager (Essen Bioscience).
Bioinformatics: Clinical mRNA expression data analyses
Expression and correlation of LPA and S1P-related genes and
pathways were analyzed in several large scale and clinical transcrip-
tome studies: (1) The MSKCC data set containing 4240 clinical
PrCa samples and metastases (Groves-Kirkby, 2010; Taylor
et al., 2010) (http://www.cbioportal.org/public-portal), (2)
PrCa transcriptome data from expO (NCBI GEO dataset
GSE2109); and (3) experimental expression data from our panel
of PrCa cell lines, comparing 2-D and 3-D culture (GEO
accession GSE19426). Normalized raw expression data were
extracted from all data sets, median centered, and analyzed
through an in-house HTML interface, using R/bioconductor-
based algorithms. Hierarchical and K-Means clustering for
S1P- and LPA-relevant genes and downstream pathways were
extracted and plotted by TreeView/Cluster (Eisen et al., 1998).
Association of gene expression patterns with clinical annotation
(grade, Gleason scores and TNM status) and patient survival
were processed with R/Bioconductor. Gene Set Enrichment
Analysis (MSigDb database) was performed across both clinical
and in house datasets, to identify canonical pathways and gene
ontology or GO categories enriched in clinical data and
experimental settings.
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